
In the U.S., GLP-1 usage reaches a new high
Americans’ use of GLP-1 injectables for weight loss has nearly quadrupled since 2024 — reshaping eating habits and demand toward high-protein foods, including dairy. The share of U.S. adults currently taking GLP-1 medications for weight loss has risen to 11% in 2026, up sharply from 3% in 2024, and 15%


